GSTM1 and GSTT1 polymorphisms associated with pain in a chemotherapy-induced peripheral neuropathy cohort
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
GSTM1 and GSTT1 polymorphisms associated with pain in a chemotherapy-induced peripheral neuropathy cohort ; volume:149 ; number:10 ; day:20 ; month:3 ; year:2023 ; pages:7405-7412 ; date:8.2023
Journal of cancer research and clinical oncology ; 149, Heft 10 (20.3.2023), 7405-7412, 8.2023
- Urheber
-
Dunn, Paul J.
Griffiths, Lyn R.
Yates, Patsy
Haupt, Larisa M.
Alexander, Kim E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00432-023-04677-3
- URN
-
urn:nbn:de:101:1-2023103012493675019604
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Dunn, Paul J.
- Griffiths, Lyn R.
- Yates, Patsy
- Haupt, Larisa M.
- Alexander, Kim E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Informative gene network for chemotherapy-induced peripheral neuropathy
Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
Chemotherapy-induced peripheral neuropathy biomarkers: current updates, challenges, and potentials
Chemotherapy-induced peripheral neuropathy: longitudinal analysis of predictors for postural control
Type of exercise may influence postural adaptations in chemotherapy‐induced peripheral neuropathy
Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients
Modulation of tissue specific membrane transporters for prevention of chemotherapy-induced peripheral neuropathy
Initial observations on sexual dysfunction as a symptom of chemotherapy-induced peripheral neuropathy
Promoting AMPK/SR-A1-mediated clearance of HMGB1 attenuates chemotherapy-induced peripheral neuropathy
A randomized pilot study of oncology massage to treat chemotherapy-induced peripheral neuropathy
Effect of Menopausal Status on Chemotherapy-Induced Peripheral Neuropathy: Single-Institution Retrospective Audit
Analysis of chemotherapy-induced peripheral neuropathy using the Japanese Adverse Drug Event Report database
Informative gene network for chemotherapy-induced peripheral neuropathy
Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
Chemotherapy-induced peripheral neuropathy biomarkers: current updates, challenges, and potentials
Chemotherapy-induced peripheral neuropathy: longitudinal analysis of predictors for postural control
Type of exercise may influence postural adaptations in chemotherapy‐induced peripheral neuropathy
Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients
Modulation of tissue specific membrane transporters for prevention of chemotherapy-induced peripheral neuropathy
Initial observations on sexual dysfunction as a symptom of chemotherapy-induced peripheral neuropathy
Promoting AMPK/SR-A1-mediated clearance of HMGB1 attenuates chemotherapy-induced peripheral neuropathy
A randomized pilot study of oncology massage to treat chemotherapy-induced peripheral neuropathy
Effect of Menopausal Status on Chemotherapy-Induced Peripheral Neuropathy: Single-Institution Retrospective Audit
Analysis of chemotherapy-induced peripheral neuropathy using the Japanese Adverse Drug Event Report database
Informative gene network for chemotherapy-induced peripheral neuropathy
Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
Chemotherapy-induced peripheral neuropathy biomarkers: current updates, challenges, and potentials
Chemotherapy-induced peripheral neuropathy: longitudinal analysis of predictors for postural control
Type of exercise may influence postural adaptations in chemotherapy‐induced peripheral neuropathy
Mirogabalin vs pregabalin for chemotherapy-induced peripheral neuropathy in pancreatic cancer patients
Modulation of tissue specific membrane transporters for prevention of chemotherapy-induced peripheral neuropathy
Initial observations on sexual dysfunction as a symptom of chemotherapy-induced peripheral neuropathy
Promoting AMPK/SR-A1-mediated clearance of HMGB1 attenuates chemotherapy-induced peripheral neuropathy
A randomized pilot study of oncology massage to treat chemotherapy-induced peripheral neuropathy
Effect of Menopausal Status on Chemotherapy-Induced Peripheral Neuropathy: Single-Institution Retrospective Audit